Diane D. Liu

<i>KRAS</i>Mutation Is an Important Predictor of Resistance to Therapy with Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Non–Small-Cell Lung Cancer

Erminia Massarelli, Marileila Varella‐Garcia, Ximing Tang et al. · Clinical Cancer Research · 2007 · 598 citations · Full text

Phase I/II Trial Evaluating the Anti-Vascular Endothelial Growth Factor Monoclonal Antibody Bevacizumab in Combination With the HER-1/Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Erlotinib for Patients With Recurrent Non–Small-Cell Lung Cancer

Roy S. Herbst, David H. Johnson, Eric D. Mininberg et al. · Journal of Clinical Oncology · 2005 · 535 citations · Full text

Lack of PTEN expression in non-small cell lung cancer could be related to promoter methylation.

Jean‐Charles Soria, Ho‐Young Lee, Janet I. Lee et al. · PubMed · 2002 · 409 citations

Epidermal Growth Factor Receptor Copy Number Alterations Correlate With Poor Clinical Outcome in Patients With Head and Neck Squamous Cancer

Stéphane Temam, Hidetoshi Kawaguchi, Adel K. El‐Naggar et al. · Journal of Clinical Oncology · 2007 · 399 citations · Full text

Overexpression of podoplanin in oral cancer and its association with poor clinical outcome

Ping Yuan, Stéphane Temam, Adel K. El‐Naggar et al. · Cancer · 2006 · 304 citations · Full text